215 related articles for article (PubMed ID: 38606512)
1. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target.
Zhang M; Huang H; Wei M; Sun M; Deng G; Hu S; Wang H; Gong Y
Curr Cancer Drug Targets; 2024; 24(2):167-177. PubMed ID: 37282642
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
Gold S; Shilatifard A
Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841
[TBL] [Abstract][Full Text] [Related]
3. BRD4 Protein as a Target for Lung Cancer and Hematological Cancer Therapy: A Review.
Zhang M; Li Y; Zhang Z; Zhang X; Wang W; Song X; Zhang D
Curr Drug Targets; 2023; 24(14):1079-1092. PubMed ID: 37846578
[TBL] [Abstract][Full Text] [Related]
4. BRD4 as a potential target for human papillomaviruses associated cancer.
Rani AQ; Bonam SR; Zhou J; Li J; Hu H; Liu X
J Med Virol; 2023 Dec; 95(12):e29294. PubMed ID: 38100650
[TBL] [Abstract][Full Text] [Related]
5. A BRD4-Targeting Photothermal Agent for Controlled Protein Degradation.
Shi M; Li Y; Pan W; Fu Z; Wang K; Liu X; Li N; Tang B
Angew Chem Int Ed Engl; 2024 May; ():e202403258. PubMed ID: 38721770
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain inhibitors and therapeutic applications.
Gajjela BK; Zhou MM
Curr Opin Chem Biol; 2023 Aug; 75():102323. PubMed ID: 37207401
[TBL] [Abstract][Full Text] [Related]
7. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
8. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
[TBL] [Abstract][Full Text] [Related]
9. BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.
Leonard B; Brand TM; O'Keefe RA; Lee ED; Zeng Y; Kemmer JD; Li H; Grandis JR; Bhola NE
Cancer Res; 2018 Aug; 78(15):4331-4343. PubMed ID: 29792310
[TBL] [Abstract][Full Text] [Related]
10. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
Nantajit D; Presta L; Sauter T; Tavassoli M
Cell Death Dis; 2022 Nov; 13(11):921. PubMed ID: 36333293
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma.
Wu Y; Wang Y; Diao P; Zhang W; Li J; Ge H; Song Y; Li Z; Wang D; Liu L; Jiang H; Cheng J
Theranostics; 2019; 9(6):1777-1793. PubMed ID: 31037138
[TBL] [Abstract][Full Text] [Related]
12. Combinational therapeutic targeting of BRD4 and CDK7 synergistically induces anticancer effects in head and neck squamous cell carcinoma.
Zhang W; Ge H; Jiang Y; Huang R; Wu Y; Wang D; Guo S; Li S; Wang Y; Jiang H; Cheng J
Cancer Lett; 2020 Jan; 469():510-523. PubMed ID: 31765738
[TBL] [Abstract][Full Text] [Related]
13. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
[TBL] [Abstract][Full Text] [Related]
14. PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer.
Zhang S; Lai Y; Pan J; Saeed M; Li S; Zhou H; Jiang X; Gao J; Zhu Y; Yu H; Zhang W; Xu Z
Adv Mater; 2024 Jun; 36(23):e2314132. PubMed ID: 38353332
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]